Effect of thalidomide dithiocarbamate analogs on the intercellular adhesion molecule-1 expression

International Immunopharmacology

Volumn 10, Issue 7, 2010, Pages 806-811

  Guirgis, Adel A ^a   Zahran, Magdy A H ^b   Mohamed, Amr S ^c   Talaat, Roba M ^a   Abdou, Bishoy Y ^b   Agwa, Hussein S ^b  

^a MENOUFIA UNIVERSITY   (Egypt)

^b Menoufia University   (Egypt)

^c Faculty of Science   (Egypt)

Author keywords

Anti tumor; ICAM 1; NO; Thalidomide dithiocarbamate analogs

Indexed keywords

ALANINE AMINOTRANSFERASE; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; LACTATE DEHYDROGENASE; NITRIC OXIDE; SERUM ALBUMIN; THALIDOMIDE; THALIDOMIDE DERIVATIVE; THALIDOMIDE DITHIOCARBAMATE DERIVATIVE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; EHRLICH ASCITES TUMOR; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA; CARCINOMA, EHRLICH TUMOR; CELL ADHESION; FEMALE; INTERCELLULAR ADHESION MOLECULE-1; L-LACTATE DEHYDROGENASE; MICE; NEOPLASM TRANSPLANTATION; NITRIC OXIDE; THALIDOMIDE; THIOCARBAMATES; TUMOR BURDEN;

EID: 77953023666     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.04.023     Document Type: Article

References (68)

1. National Cancer Institute. The nation's investment in cancer research: a plan and budget proposal for fiscal year 2007 (October 2005), US National Institutes of Health, Washington, DC NIH Publication No. 06-5856
2. Lowe S.W., and Lin A.W. Apoptosis in cancer. Carcinogenesis 21 (2000) 485-495
3. Chun K.H., Kosmeder II J.W., Sun S., Pezzuto J.M., Lotan R., Hong W.K., et al. Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells. J Natl Cancer Inst 95 (2003) 291-302
4. Leleu X., Micol J.B., Guieze R., Berthon C., Kuhnovsky F., Terriou L., et al. Thalidomide: mechanisms of action and new insights in hematology. Rev Med Interne 26 (2005) 119-127
5. Teo S.K., Stirling D.I., and Zelidis J.B. Thalidomide as a novel therapeutic agent: new uses for an old product. Drug Discov Today 10 (2005) 107-114
6. Franks M.E., Macpherson G.R., and Figg W.D. Thalidomide. Lancet 363 (2004) 1802-1811
7. Madan B., Prasad A.K., Parmar V.S., and Ghosh B. 1, 4-Dihydroxyxanthone modulates the adhesive property of endothelial cells by inhibiting intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin. Bioorg Med Chem 12 (2004) 1431-1437
8. Aeed P.A., Nakajima M., and Welch D.R. The role of polymorphonuclear leukocytes (PMN) on the growth and metastatic potential of 13762NF mammary adenocarcinoma cells. Int J Cancer 42 (1988) 748-759
9. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
10. Mantovani A., Bottazzi B., Colotta F., Sozzani S., and Ruco L. The origin and function of tumor-associated macrophages. Immunol Today 13 (1992) 265-270
11. Mantovani A., Bussolino F., and Dejana E. Cytokine regulation of endothelial cell function. FASEB J 6 (1992) 2591-2599
12. Dymicka-Piekarska V., and Kemona H. Does colorectal cancer clinical advancement affect adhesion molecules (sP-selectin, sE-selectin and ICAM-1) concentration?. Thromb Res 124 (2009) 80-83
13. Yang L., Froio R.M., Sciuto T.E., Dvorak A.M., Alon R., and Luscinskas F.W. ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow. Blood 106 (2005) 584-592
14. Choi Y.L., Xuan Y.H., Shin Y.K., Chae S.W., Kook M.C., Sung R.H., et al. An immunohistochemical study of the expression of adhesion molecules in gallbladder lesions. J Histochem Cytochem 52 (2004) 591-601
15. Hemmerlein B., Scherbening J., Kugler A., and Radzun H. Expression of VCAM-1, ICAM-1, E- and P-selectin and tumour-associated macrophages in renal cell carcinoma. J Histopathol 37 (2000) 78-3
16. Lin Y.C., Shun C.T., Wu M.S., and Chen C.C. A novel anticancer effect of thalidomide: inhibition of intercellular adhesion molecule-1-mediated cell invasion and metastasis through suppression of nuclear factor-kappaB. Clin Cancer Res 12 (2006) 7165-7173
17. Tempia-Caliera A.A., Horvath L.Z., Zimmermann A., Tihanyi T.T., Korc M., Friess H., et al. Adhesion molecules in human pancreatic cancer. J Surg Oncol 79 (2002) 93-100
18. Basoglu M., Atamanalp S.S., Yildirgan M.I., Aydinli B., Ozturk G., Akca F., et al. Correlation between the serum values of soluble intercellular adhesion molecule-1 and total sialic acid levels in patients with breast cancer. Eur Surg Res 39 (2007) 136-140
19. Dowlati A., Gray R., Sandler A.B., Schiller J.H., and Johnson D.H. Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab - an Eastern Cooperative Oncology Group Study. Clin Cancer Res 14 (2008) 1407-1412
20. Brooks K.J., Coleman E.J., and Vitetta E.S. The antitumor activity of an anti-CD54 antibody in SCID mice xenografted with human breast, prostate, non-small cell lung, and pancreatic tumor cell lines. Int J Cancer 123 (2008) 2438-2445
21. Liang S., Slattery M.J., Wagner D., Simon S.I., and Dong C. Hydrodynamic shear rate regulates melanoma leukocyte aggregation, melanoma adhesion to the endothelium, and subsequent extravasation. Ann Biomed Eng 36 (2008) 661-671
22. Sessa W.C. Regulation of endothelial derived nitric oxide in health and disease. Mem Inst Oswaldo Cruz 100 (2005) 15-18
23. Sessa W.C. The nitric oxide synthase family of proteins. J Vasc Res 31 (1994) 131-143
24. Lee J.S., Decker N.K., Chatterjee S., Yao J., Friedman S., and Shah V. Mechanisms of nitric oxide interplay with Rho GTPase family members in modulation of actin membrane dynamics in pericytes and fibroblasts. Am J Pathol 166 (2005) 1861-1870
25. Babaei S., Teichert-Kuliszewska K., Zhang Q., Jones N., Dumont D.J., and Stewart D.J. Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide. Am J Pathol 162 (2003) 1927-1936
26. Chen J.X., Lawrence M.L., Cunningham G., Christman B.W., and Meyrick B. HSP90 and Akt modulate Ang-1-induced angiogenesis via NO in coronary artery endothelium. J Appl Physiol 96 (2004) 612-620
27. Zahran M.A.H., Salem T.A.R., Samaka R.M., Agwa H.S., and Awad A.R. Design, synthesis and antitumor evaluation of novel thalidomide dithiocarbamate and dithioate analogs against Ehrlich ascites carcinoma-induced solid tumor in Swiss albino mice. Bioorg Med Chem 16 (2008) 9708-9718
28. Mohamed F.E., Tarek A.S., Mohamed F.E., and Mohamed O. Tannic acid potentially inhibits tumor growth, raises survival of mice bearing syngeneic tumor. Egypt J Biochem Mol Biol 21 (2003) 139-155
29. Papadopoulos D., Kimler B.F., Estes N.C., and Durham F.J. Growth delay effect of combined interstitial hypertzermia and brachytherapy in a rat solid tumor model. Anticancer Res 9 (1989) 45-48
30. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 6 (1969) 24-28
31. Doumas B.T., Watson W.A., and Biggs H.G. Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta 31 (1971) 87-96
32. Cabaud P.G., and Wroblewski F. Colorimetric measurement of lactic dehydrogenase activity of body fluids. Am J Clin Pathol 30 (1958) 234-236
33. Miranda K.M., Espey M.G., and Wink D.A. A rapid, simple spectrophotometric method for simultaneous detection of Nitrate and Nitrite. Biol Chem 5 (2001) 62-71
34. Wang J., and Mazza G. Inhibitory effects of anthocyanins and other phenolic compounds on nitric oxide production in LPS/IFN-activated RAW 264.7 macrophages. J Agric Food Chem 50 (2002) 850-857
35. Silverstein H., Dervot K., and Oscar D. Studies on carbohydrate metabolism and different types of tumors bearing animals. Lancet 22 (1988) 40-45
36. Oscar C. Biopharmacological studies on certain new anticancer drugs. J Biochem 110 (1988) 701-707
37. Tagmizyan W.A. Metabolism of impaired glucose in patients with neoplasia. Am Biol 2 (1990) 53-58
38. Fahim F.A., Abd-Allah N.M., and Esmat A.Y. Some metabolic aspects in normal and tumor-bearing mice treated with a natural anthraquinone. J Tumor Marker Oncol 8 (1993) 35-42
39. Kind P.R.N., Gordon M., Laverick M., Nias A.H., and Slavin B.M. The effect of C3H mouse mammary tumor on the levels of serum and urine analytes in vivo. Br J Cancer 52 (1985) 607-612
40. Hyodo I., Jinno K., Yanimizu M., Hosokawa Y., Nishikawa Y., Akiyama M., et al. Detection of circulating intercellular adhesion molecule-1 in hepatocellular carcinoma. Int J Cancer 55 (1993) 775-779
41. Shimizu Y., Minemura M., Tsukishiro T., Kashii Y., Miyamata M., Vishimori H., et al. Serum concentration of intercellular adhesiom molecule-1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis. Hepatology 22 (1995) 525-531
42. Natali P.G., Hamby C.V., Felding-Habermann B., Liang B., Nicotra M.R., Di-Filippo F., et al. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Res 57 (1997) 1554-1560
43. Huang W.C., Chan S.T., Yang T.L., Tzeng C.C., and Chen C.C. Inhibition of ICAM-1 gene expression, monocyte adhesion and cancer cell invasion by targeting IKK complex: molecular and functional study of novel a-methylene-g-butyrolactone derivatives. Carcinogenesis 25 (2004) 1925-1934
44. Rosette C., Roth R.B., Oeth P., Braun A., Kammerer S., Ekblom J., et al. Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis 26 (2005) 943-950
45. Smith M.E., and Thomas J.A. Cellular expression of lymphocyte function associated antigens and the intercellular adhesion molecule-1 in normal tissue. J Clin Pathol 43 (1990) 893-900
46. Yokomori H., Oda M., Ogi M., Wakabayashi G., Kawachi S., Yoshimura K., et al. Expression of adhesion molecules on mature cholangiocytes in canal of Hering and bile ductules in wedge biopsy samples of primary biliary cirrhosis. World J Gastroenterol 11 (2005) 4382-4389
47. Panasiuk A., Prokopowicz D., and Panasiuk B. Monocyte chemotactic protein-1 and soluble adhesion molecules as possible prognostic markers of the efficacy of antiviral treatment in chronic hepatitis C. World J Gastroenterol 10 (2004) 3639-3642
48. Sun J.J., Zhou X.D., Liu Y.K., Tang Z.Y., Fing J.X., Zhou G., et al. Invasion and metastasis of liver cancer: expression of intercellular adhesion molecule 1. J Cancer Res Clin Oncol 125 (1999) 28-34
49. Peng L.V., Shelley C.P., Yanjv X., Shiquan L., and Hesheng L. Effect of thalidomide on the expression of adhesion molecules in rat liver cirrhosis. Mediators Inflamm 4 (2006) 1-10
50. Settles B., Stevenson A., and Wilson K. Down-regulation of cell adhesion molecules LFA-1 and ICAM-1 after in vitro treatment with the anti-TNF-α agent thalidomide. Cell Mol Biol 47 (2001) 1105-1114
51. Meierhofer C., Dunzendorfer S., and Wiedermann C.J. Theoretical basis for the activity of thalidomide. BioDrugs 15 (2001) 681-703
52. Schäefers M., Schmidt C., Vogel C., Toyka K.V., and Sommer C. Tumor necrosis factor-α (TNF) regulates the expression of ICAM-1 predomonantly through TNF receptor 1 after chronic constriction injury of mouse sciatic nerve. Acta Neuropathol 104 (2002) 197-205
53. Osborn L., Hession C., Tizard R., Vassallo C., Luhowskyj S., Chi-Rosso G., et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 59 (1989) 1203-1211
54. Moreira A.L., Sampaio E.P., Zmuidzinas A., Frindt P., Smith K.A., and Kaplan G. Thalidomide exerts its inhibitory action on tumor necrosis factor α by enhancing mRNA degradation. J Exp Med 177 (1993) 1675-1680
55. Sampaio E.P., Hernandez M.O., Carvalho D.S., and Sarno E.N. Management of erythema nodosum leprosum by thalidomide: thalidomide analogues inhibit M. leprae-induced TNF-α production in vitro. J Biomed Pharmacother 56 (2002) 13-19
56. Keifer J.A., Guttridge D.C., Ashburner B.P., and Baldwin A. Inhibition of NF-κB activity by thalidomide through suppression of Iκ B kinase activity. J Biol Chem 276 (2001) 22382-22387
57. Gupta D., Treon S.P., Shima Y., Hideshima T., Podar K., Tai Y.T., et al. Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications. Leukemia 15 (2001) 1950-1961
58. D'Amato R., Loughnan M.S., Flynn E., and Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91 (1994) 4082-4085
59. Dredge K., Marriott J.B., and Dalgleish A.G. Immunological effects of thalidomide and its chemical and functional analogs. Crit Rev Immunol 22 (2002) 425-437
60. Lentzsch S., LeBlanc R., Podar K., Davies F., Lin B., Hideshima T., et al. Immunomodulatory analogs of thalidomide inhibit growth of Hs Sultan cells and angiogenesis in vivo. Leukemia 17 (2003) 41-44
61. Bredt D.S., and Snyder S.H. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63 (1994) 175-195
62. Dawson T.M., and Dawson V.L. Review: nitric oxide: actions and pathological roles. Neuroscientist 1 (1995) 7-18
63. Thomsen L.L., and Miles D.W. Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Rev 17 (1998) 107-118
64. Morbidelli L., Chang C.H., Douglas J.G., Granger H.J., Ledda F., and Ziche M. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 270 (1996) H411-H415
65. Jenkins D.C., Charles I.G., Thomsen L.L., Moss D.W., Holmes L.S., Baylis S.A., et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 92 (1995) 4392-4396
66. Rumiko S., Hiroko S., Aya T., Hiroyuki M., and Yuichi H. Thalidomide as a nitric oxide synthase inhibitor and its structural development. Chem Pharm Bull 52 (2004) 498-499
67. Parenti A., Morbidelli L., Cui X.L., Douglas J.G., Hood J.D., Granger H.J., et al. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in postcapillary endothelium. J Biol Chem 273 (1998) 4220-4226
68. Bouloumie A., Schini-Kerth V.B., and Busse R. Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells. Cardiovasc Res 41 (1999) 773-780